Computerized Prescribing Alerts and Group Academic Detailing to Reduce the Use of Potentially Inappropriate Medications in Older People

Harvard University, Cambridge, Massachusetts, United States
Journal of the American Geriatrics Society (Impact Factor: 4.57). 07/2006; 54(6):963-8. DOI: 10.1111/j.1532-5415.2006.00734.x
Source: PubMed


To examine the effect of replacing drug-specific computerized prescribing alerts with age-specific alerts on rates of dispensing potentially inappropriate medications in older people and to determine whether group academic detailing enhances the effectiveness of these alerts.
Cluster-randomized trial of group academic detailing and interrupted time-series analysis.
Fifteen clinics of a staff-model health maintenance organization.
Seven practices (113 clinicians, 24,119 patients) were randomly assigned to receive age-specific prescribing alerts plus the academic detailing intervention; eight practices (126 clinicians, 26,805 patients) received alerts alone. Prior implementation of drug-specific alerts established a downward trend in use of target medications that served as the baseline trend for the present study.
The computerized age-specific alerts occurred at the time of prescribing a targeted potentially inappropriate medication (e.g., tertiary tricyclic amine antidepressants, long-acting benzodiazepines, propoxyphene) and suggested an alternative medication. Clinicians at seven sites were randomized to group academic detailing, an interactive educational program delivering evidence-based information.
Number of target medications dispensed per 10,000 patients per quarter, 2 years before and 1.5 years after the replacement of drug-specific with age-specific alerts.
Age-specific alerts resulted in a continuation of the effects of the drug-specific alerts without measurable additional effect (P=.75 for level change), but the age-specific alerts led to fewer false-positive alerts for clinicians. Group academic detailing did not enhance the effect of the alerts.
Age-specific alerts sustained the effectiveness of drug-specific alerts to reduce potentially inappropriate prescribing in older people and resulted in a considerably decreased burden of the alerts.

Download full-text


Available from: Nancy Perrin, Oct 07, 2015
1 Follower
43 Reads
  • Source
    • "However, it appears that more integrated approaches are needed to significantly reduce the burden of PIP. Previously suggested approaches in the UK have included identifying the main PIP issues nationally (which this study fulfilled) and the use of alert systems in the computers of primary care physicians to identify PIP at the time of prescribing [43]. Such systems have effectively reduced the level of newly prescribed inappropriate medications in the US [44] and similar pharmacist-led information technology interventions in the UK reduced medication errors in primary care, indicating the potential for future development [45]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Potentially inappropriate prescribing (PIP) in older people is associated with increases in morbidity, hospitalisation and mortality. The objective of this study was to estimate the prevalence of and factors associated with PIP, among those aged ≥70 years, in the United Kingdom, using a comprehensive set of prescribing indicators and comparing these to estimates obtained from a truncated set of the same indicators. Methods: A retrospective cross-sectional study was carried out in the UK Clinical Practice Research Datalink (CPRD), in 2007. Participants included those aged ≥ 70 years, in CPRD. Fifty-two PIP indicators from the Screening Tool of Older Persons Potentially Inappropriate Prescriptions (STOPP) criteria were applied to data on prescribed drugs and clinical diagnoses. Overall prevalence of PIP and prevalence according to individual STOPP criteria were estimated. The relationship between PIP and polypharmacy (≥4 medications), comorbidity, age, and gender was examined. A truncated, subset of 28 STOPP criteria that were used in two previous studies, were further applied to the data to facilitate comparison. Results: Using 52 indicators, the overall prevalence of PIP in the study population (n = 1,019,491) was 29%. The most common examples of PIP were therapeutic duplication (11.9%), followed by use of aspirin with no indication (11.3%) and inappropriate use of proton pump inhibitors (PPIs) (3.7%). PIP was strongly associated with polypharmacy (Odds Ratio 18.2, 95% Confidence Intervals, 18.0-18.4, P < 0.05). PIP was more common in those aged 70-74 years vs. 85 years or more and in males. Application of the smaller subset of the STOPP criteria resulted in a lower PIP prevalence at 14.9% (95% CIs 14.8-14.9%) (n = 151,598). The most common PIP issues identified with this subset were use of PPIs at maximum dose for > 8 weeks, NSAIDs for > 3 months, and use of long-term neuroleptics. Conclusions: PIP was prevalent in the UK and increased with polypharmacy. Application of the comprehensive set of STOPP criteria allowed more accurate estimation of PIP compared to the subset of criteria used in previous studies. These findings may provide a focus for targeted interventions to reduce PIP.
    BMC Geriatrics 06/2014; 14(1):72. DOI:10.1186/1471-2318-14-72 · 1.68 Impact Factor
  • Source
    • "In fact, many organizations have begun developing and evaluating such systems as well as applications that link electronic medical records (EMR) and inpatient computerized physician order entry systems (CPOE) to facilitate effective medication reconciliation [41-44]. Such applications can generate an accurate pre-admission and discharge medication list, identify patients at risk of ADEs, allergies, adherence and persistence problems, as well as send alerts to patients, prescribers and other health care professionals [45,46]. Integration of e-health technology also offers the possibility of using administrative claims data repositories as a rich source of information. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Medication reconciliation at admission, transfer and discharge has been designated as a required hospital practice to reduce adverse drug events. However, implementation challenges have resulted in poor hospital adherence. The aim of this study was to assess the processes required to carry out medication reconciliation: the health professionals involved, and the tasks and time devoted to medication reconciliation in general hospital settings. A time-and-motion study design was used. Using a systematic sample of patients admitted and discharged from geriatric, medical and surgical units in two academic centers, health professionals involved in medication reconciliation were observed and timed. Descriptive statistics were used to summarize the number of professionals, tasks performed, and mean time devoted. 1 to 3 professionals from 2 disciplines (medicine and pharmacy) were involved in the medication reconciliation process. Geriatric reconciliations took the most time to complete at admission (mean: 92.2 minutes (SD = 44.3)) and discharge (mean: 29.0 minutes (SD = 23.8)), then internal medicine at admission (mean: 46.2 minutes (SD = 21.1) and 19.4 (SD = 11.7) minutes at discharge) and general surgery minutes at discharge (mean: 9.9 (SD = 18.2)). Considerable differences in order, type and number of tasks performed were noted between and within units. Tasks independent of direct patient interaction took more than twice the time required to complete than tasks requiring patient interaction. Lack of coordination, specialized training and agreement on the roles and responsibilities of professionals are among the most probable reasons for work-flow inefficiencies, possibly variability in quality, and time required for the current medication reconciliation process. A better understanding of the admission process in general surgery is required. Standardization and use of electronic tools could improve efficiency and hospital adherence.
    BMC Health Services Research 11/2013; 13(1):485. DOI:10.1186/1472-6963-13-485 · 1.71 Impact Factor
  • Source
    • "The current analysis, like other reviews, suggests group education interventions may be beneficial but the findings are inconclusive [78,79]. We found that peer leader group education was effective in changing medication use but was less effective than one-to-one academic detailing [16,31,32]. The absence of incremental impact of group education when combined with computer-based alerts, as reported by Simon et al [32] and Feldstein et al [31], may reflect the weakness of the approach or the superior effectiveness of computerized alerts in changing the particular outcomes targeted in these interventions. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Managed care organizations use a variety of strategies to reduce the cost and improve the quality of medication use. The effectiveness of such policies is not well understood. The objective of this research was to update a previous systematic review of interventions, published between 1966 and 2001, to improve the quality and efficiency of medication use in the US managed care setting. We searched MEDLINE and EMBASE for publications from July 2001 to January 2007 describing interventions targeting drug use conducted in the US managed care setting. We categorized studies by intervention type and adequacy of research design using commonly accepted criteria. We summarized the outcomes of well-controlled strategies and documented the significance and magnitude of effects for key study outcomes. We identified 164 papers published during the six-year period. Predominant strategies were: educational interventions (n = 20, including dissemination of educational materials, and group or one-to-one educational outreach); monitoring and feedback (n = 22, including audit/feedback and computerized monitoring); formulary interventions (n = 66, including tiered formulary and patient copayment); collaborative care involving pharmacists (n = 15); and disease management with pharmacotherapy as a primary focus (n = 41, including care for depression, asthma, and peptic ulcer disease). Overall, 51 studies met minimum criteria for methodological adequacy. Effective interventions included one-to-one academic detailing, computerized alerts and reminders, pharmacist-led collaborative care, and multifaceted disease management. Further, changes in formulary tier-design and related increases in copayments were associated with reductions in medication use and increased out-of-pocket spending by patients. The dissemination of educational materials alone had little or no impact, while the impact of group education was inconclusive. There is good evidence for the effectiveness of several strategies in changing drug use in the managed care environment. However, little is known about the cost-effectiveness of these interventions. Computerized alerts showed promise in improving short-term outcomes but little is known about longer-term outcomes. Few well-designed, published studies have assessed the potential negative clinical effects of formulary-related interventions despite their widespread use. However, some evidence suggests increases in cost sharing reduce access to essential medicines for chronic illness.
    BMC Health Services Research 02/2008; 8(1):75. DOI:10.1186/1472-6963-8-75 · 1.71 Impact Factor
Show more

Similar Publications